Takeda Pharmaceutical Co Ltd (FRA:TKD)
€ 26.43 -0.5 (-1.86%) Market Cap: 42.49 Bil Enterprise Value: 71.48 Bil PE Ratio: 45.29 PB Ratio: 0.86 GF Score: 72/100

Takeda Pharmaceutical Co Ltd Lysosomal Storage Diseases Investor Seminar Transcript

Oct 3, 2022 / 04:00 AM GMT
Release Date Price: €26.8 (+3.59%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

4502.T - Takeda Pharmaceutical Co Ltd
Takeda Pharmaceutical Co Ltd Lysosomal Storage Diseases Investor Seminar
Oct 04, 2022 / 04:00AM GMT

=====================
Conference Call Participants
=====================
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Shinichiro Muraoka
Morgan Stanley, Research Division - Research Analyst
* Sanghun Iwashiro
* Suzuki Gen

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified Company Representative, [1]
--------------------------------------------------------------------------------
Thank you very much for joining us today for Takeda's Online Disease Seminar despite your very busy schedule. I'm the master of ceremony today, my name is (inaudible) from IR. Thank you very much for this opportunity. Allow me to explain about the language
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot